Related Experiment Video
Updated: Feb 2, 2026

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
Published on: March 14, 2014
Effects of RhoA and RhoC upon the sensitivity of prostate cancer cells to glutamine deprivation
Luciana Bueno De Paiva1, Vanessa Aline Bernusso1, João Agostinho Machado-Neto2,3
1Hematology and Bloood Transfusion Center, University of Campinas , Campinas, São Paulo, Brazil.
Abstract:
RhoA and RhoC contribute to the regulation of glutamine metabolism, which is a crucial determinant of cell growth in some types of cancer. Here we investigated the participation of RhoA and RhoC in the response of prostate cancer cells to glutamine deprivation. We found that RhoA and RhoC activities were up- or downregulated by glutamine reduction in PC3 and LNCaP cell lines, which was concomitant to a reduction in cell number and proliferation. Stable overexpression of wild type RhoA or RhoC did not alter the sensitivity to glutamine deprivation. However, PC3 cells expressing dominant negative RhoAN19 or RhoCN19 mutants were more resistant to glutamine deprivation. Our results indicate that RhoA and RhoC activities could affect cancer treatments targeting the glutamine pathway.
Insights
RhoA and RhoC proteins regulate glutamine metabolism, impacting cancer cell growth. Inhibiting these proteins, RhoA (Ras homolog family member A) and RhoC, may enhance prostate cancer treatments targeting glutamine pathways.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Metabolism
Background:
- Glutamine metabolism is critical for cancer cell proliferation and survival.
- RhoA and RhoC are small GTPases involved in cell signaling and cytoskeletal regulation.
- The role of RhoA and RhoC in prostate cancer cell response to glutamine deprivation remains unclear.
Purpose of the Study:
- To investigate the involvement of RhoA and RhoC in prostate cancer cell adaptation to glutamine deprivation.
- To determine the impact of RhoA and RhoC activity modulation on prostate cancer cell viability under glutamine-limited conditions.
Main Methods:
- Utilized PC3 and LNCaP prostate cancer cell lines.
- Assessed RhoA and RhoC activities in response to glutamine reduction.
- Examined the effect of stable overexpression of wild-type RhoA/RhoC and dominant-negative mutants (RhoAN19, RhoCN19) on cell proliferation and survival under glutamine deprivation.
Main Results:
- Glutamine reduction led to altered RhoA and RhoC activities in PC3 and LNCaP cells, correlating with reduced cell number and proliferation.
- Stable overexpression of wild-type RhoA or RhoC did not affect sensitivity to glutamine deprivation.
- PC3 cells expressing dominant-negative RhoAN19 or RhoCN19 mutants exhibited increased resistance to glutamine deprivation.
Conclusions:
- RhoA and RhoC activities play a significant role in prostate cancer cell response to glutamine deprivation.
- Modulating RhoA and RhoC activity could represent a therapeutic strategy to enhance the efficacy of cancer treatments targeting glutamine metabolism.
Related Concept Videos
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Biological Effects of Radiation
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...
Framing Effects
Cancer Cell Migration through Invadopodia
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

